UBS Group’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Sell
7,478
-133
-2% -$5.33K ﹤0.01% 6520
2026
Q1
$275K Buy
7,611
+67
+0.9% +$2.57K ﹤0.01% 6451
2025
Q4
$290K Buy
7,544
+903
+14% +$34K ﹤0.01% 6378
2025
Q3
$240K Buy
6,641
+31
+0.5% +$1.08K ﹤0.01% 6567
2025
Q2
$226K Sell
6,610
-6,294
-49% -$200K ﹤0.01% 6639
2025
Q1
$403K Buy
+12,904
New +$421K ﹤0.01% 6024
2024
Q4
Sell
-628
Closed -$20.5K 10301
2024
Q3
$20.5K Buy
+628
New +$19.7K ﹤0.01% 7363

Other funds holding QLTY

UBS Group's QLTY Position: Q2 2026 in Review

UBS Group reduced its GMO US Quality ETF (QLTY) stake by 1.7% in Q2 2026, selling an estimated $5.33K and leaving 7,478 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #6520.

UBS Group first reported a position in QLTY in Q3 2024 and has held it in 7 quarters since. The position peaked at $403K in Q1 2025. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • UBS Group held 7,478 shares of GMO US Quality ETF worth $311K as of Q2 2026.
  • UBS Group sold 133 GMO US Quality ETF shares in Q2 2026, an estimated $5.33K.
  • GMO US Quality ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6520 holding.
  • UBS Group first reported a position in GMO US Quality ETF in Q3 2024 and has held it in 7 quarters since.
  • UBS Group's GMO US Quality ETF position peaked at $403K in Q1 2025.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.